Lupus Research Alliance Response to Positive Trial Testing Obinutuzumab (Gazyva®) for Lupus Nephritis
- Sunday, November 10, 2019, 7:10
- Environment
- Add a comment
NEW YORK, Nov. 10, 2019 /PRNewswire/ — The Lupus Research Alliance (LRA) is pleased to acknowledge positive results presented at the American Society of Nephrology (ASN) and the 2019 ACR/ARP Annual Meeting demonstrating the effectiveness of obinutuzumab (Gazyva®), a type I anti-CD20…
About the Author
adminasapcorp has written 41779 stories on this site.